# Therapair IP Licensing Agreement

## ðŸ“‹ Agreement Overview

**Licensors:** Prequel Pty Ltd (65%) | Unison Mental Health Pty Ltd (35%)  
**Licensee:** Therapair Products Pty Ltd  
**Purpose:** License Therapair IP to the company for commercialization  
**Effective Date:** [DATE]  
**Version:** 1.0

---

## 1. DEFINITIONS

### **1.1 Key Terms**
- **"Licensors"** means Prequel Pty Ltd and Unison Mental Health Pty Ltd collectively
- **"Licensee"** means Therapair Products Pty Ltd
- **"Licensed IP"** means all intellectual property licensed under this agreement
- **"Product"** means the Therapair matching technology and platform
- **"Territory"** means worldwide
- **"Term"** means the duration of this agreement

### **1.2 Licensed IP**
The Licensed IP includes but is not limited to:
- **Patents:** All patents related to the Product
- **Trademarks:** All trademarks related to the Product
- **Copyrights:** All copyrights related to the Product
- **Trade Secrets:** All trade secrets related to the Product
- **Know-How:** All know-how related to the Product
- **Software:** All software and code related to the Product

---

## 2. GRANT OF LICENSE

### **2.1 License Grant**
The Licensors hereby grant to the Licensee:
- **Exclusive License:** Exclusive right to use the Licensed IP
- **Commercialization Rights:** Right to commercialize the Licensed IP
- **Modification Rights:** Right to modify and improve the Licensed IP
- **Sublicensing Rights:** Right to sublicense the Licensed IP
- **Territory:** Worldwide territory

### **2.2 License Scope**
The license includes:
- **Development Rights:** Right to develop and improve the Product
- **Manufacturing Rights:** Right to manufacture and produce the Product
- **Marketing Rights:** Right to market and promote the Product
- **Sales Rights:** Right to sell and distribute the Product
- **Service Rights:** Right to provide services using the Product

### **2.3 License Restrictions**
The license is subject to:
- **Quality Standards:** Must meet agreed quality standards
- **Brand Guidelines:** Must follow brand guidelines
- **Clinical Standards:** Must meet clinical standards
- **Legal Compliance:** Must comply with applicable laws
- **Reporting Requirements:** Must provide regular reports

---

## 3. LICENSING FEES

### **3.1 License Fee Structure**
- **Initial License Fee:** AUD $50,000 (paid on execution)
- **Annual License Fee:** AUD $25,000 per year
- **Royalty Rate:** 5% of gross revenue
- **Minimum Royalty:** AUD $50,000 per year
- **Payment Terms:** Quarterly payments

### **3.2 Revenue Sharing**
- **Gross Revenue:** All revenue from Licensed IP
- **Royalty Calculation:** 5% of gross revenue
- **Payment Schedule:** Quarterly within 30 days
- **Reporting:** Monthly revenue reports
- **Audit Rights:** Right to audit revenue

### **3.3 Payment Terms**
- **Initial Payment:** Due on execution
- **Annual Payments:** Due on anniversary date
- **Royalty Payments:** Due within 30 days of quarter end
- **Late Fees:** 1.5% per month on overdue amounts
- **Currency:** All payments in Australian dollars

---

## 4. LICENSOR RIGHTS

### **4.1 Prequel Rights (65%)**
- **Technical Oversight:** Oversight of technical development
- **Quality Control:** Quality control and standards
- **Modification Approval:** Approval of major modifications
- **Revenue Sharing:** 65% of licensing revenue
- **Decision Making:** 65% voting rights on major decisions

### **4.2 Unison Rights (35%)**
- **Clinical Oversight:** Oversight of clinical aspects
- **Ethical Standards:** Ethical standards and compliance
- **Clinical Approval:** Approval of clinical modifications
- **Revenue Sharing:** 35% of licensing revenue
- **Veto Rights:** Veto on clinical/ethical decisions

### **4.3 Joint Rights**
- **Board Representation:** Both parties on company board
- **Strategic Input:** Input on strategic decisions
- **Quality Standards:** Joint quality standards
- **Compliance Oversight:** Joint compliance oversight

---

## 5. LICENSEE OBLIGATIONS

### **5.1 Development Obligations**
- **Product Development:** Develop and improve the Product
- **Quality Standards:** Maintain agreed quality standards
- **Clinical Standards:** Maintain clinical standards
- **Security Standards:** Maintain security standards
- **Compliance:** Comply with applicable laws

### **5.2 Commercialization Obligations**
- **Market Development:** Develop target markets
- **Customer Acquisition:** Acquire and retain customers
- **Revenue Generation:** Generate revenue from Licensed IP
- **Brand Management:** Manage and protect brand
- **Partnership Development:** Develop strategic partnerships

### **5.3 Reporting Obligations**
- **Monthly Reports:** Monthly progress reports
- **Quarterly Reports:** Quarterly financial reports
- **Annual Reports:** Annual comprehensive reports
- **Ad Hoc Reports:** Reports as requested
- **Audit Cooperation:** Cooperate with audits

---

## 6. INTELLECTUAL PROPERTY

### **6.1 Ownership**
- **Licensed IP:** Remains owned by Licensors
- **Improvements:** Licensee owns improvements
- **New IP:** Licensee owns new IP developed
- **Joint IP:** Joint ownership of collaborative IP
- **Background IP:** Retained by respective parties

### **6.2 Protection**
- **Patent Protection:** Licensors maintain patent protection
- **Trademark Protection:** Licensors maintain trademark protection
- **Copyright Protection:** Licensors maintain copyright protection
- **Trade Secret Protection:** Joint trade secret protection
- **Enforcement:** Joint enforcement of IP rights

### **6.3 Improvements**
- **Improvement Rights:** Licensee can improve Licensed IP
- **Improvement Ownership:** Licensee owns improvements
- **Improvement Licensing:** Licensee licenses improvements to Licensors
- **Improvement Revenue:** Shared revenue from improvements
- **Improvement Protection:** Joint protection of improvements

---

## 7. QUALITY CONTROL

### **7.1 Quality Standards**
- **Technical Standards:** Must meet technical standards
- **Clinical Standards:** Must meet clinical standards
- **Security Standards:** Must meet security standards
- **Performance Standards:** Must meet performance standards
- **Compliance Standards:** Must meet compliance standards

### **7.2 Quality Monitoring**
- **Regular Reviews:** Regular quality reviews
- **Testing Requirements:** Required testing and validation
- **Certification:** Required certifications and approvals
- **Audit Rights:** Right to audit quality
- **Remediation:** Required remediation of issues

### **7.3 Quality Improvement**
- **Continuous Improvement:** Continuous quality improvement
- **Best Practices:** Implementation of best practices
- **Industry Standards:** Compliance with industry standards
- **Innovation:** Encouragement of innovation
- **Excellence:** Pursuit of excellence

---

## 8. TERMINATION

### **8.1 Termination Events**
- **Breach:** Material breach not cured within 30 days
- **Insolvency:** Bankruptcy or insolvency of Licensee
- **Non-Payment:** Non-payment of fees not cured within 30 days
- **Quality Failure:** Failure to meet quality standards
- **Mutual Agreement:** Termination by mutual agreement

### **8.2 Effect of Termination**
- **License Termination:** License terminates immediately
- **IP Return:** Return all Licensed IP and materials
- **Confidentiality:** Confidentiality obligations continue
- **Revenue Sharing:** Revenue sharing continues for existing contracts
- **Transition:** Reasonable transition period

### **8.3 Post-Termination Rights**
- **Existing Contracts:** Can fulfill existing contracts
- **Transition Period:** 90-day transition period
- **IP Return:** Return all Licensed IP
- **Confidentiality:** Maintain confidentiality
- **Non-Compete:** 12-month non-compete period

---

## 9. CONFIDENTIALITY

### **9.1 Confidential Information**
- **Licensed IP:** All Licensed IP is confidential
- **Business Information:** All business information
- **Technical Information:** All technical information
- **Financial Information:** All financial information
- **Strategic Information:** All strategic information

### **9.2 Confidentiality Obligations**
- **Non-Disclosure:** Cannot disclose confidential information
- **Non-Use:** Cannot use for other purposes
- **Protection:** Must protect confidential information
- **Return:** Must return on termination
- **Perpetual:** Obligations continue after termination

### **9.3 Exceptions**
- **Public Information:** Information that becomes public
- **Independent Development:** Information developed independently
- **Legal Requirements:** Disclosure required by law
- **Consent:** Disclosure with written consent

---

## 10. DISPUTE RESOLUTION

### **10.1 Dispute Resolution Process**
1. **Direct Negotiation:** 30 days good faith negotiation
2. **Mediation:** 60 days mediation with agreed mediator
3. **Arbitration:** Binding arbitration under Australian Arbitration Act
4. **Litigation:** Court proceedings as last resort

### **10.2 Governing Law**
- **Jurisdiction:** Victoria, Australia
- **Governing Law:** Australian law
- **Courts:** Victorian courts have jurisdiction
- **Language:** English language for all proceedings

---

## 11. GENERAL PROVISIONS

### **11.1 Entire Agreement**
This agreement constitutes the entire agreement between the parties and supersedes all prior negotiations, representations, or agreements.

### **11.2 Amendment**
This agreement may only be amended by written agreement signed by all parties.

### **11.3 Severability**
If any provision is held invalid or unenforceable, the remaining provisions shall remain in full force and effect.

### **11.4 Assignment**
This agreement may not be assigned without written consent of all parties.

### **11.5 Notices**
All notices must be in writing and delivered to the registered office of each party.

---

## 12. SIGNATURES

**Prequel Pty Ltd**  
Signature: _________________________  
Name: [AUTHORIZED REPRESENTATIVE]  
Title: [TITLE]  
Date: _________________________

**Unison Mental Health Pty Ltd**  
Signature: _________________________  
Name: [AUTHORIZED REPRESENTATIVE]  
Title: [TITLE]  
Date: _________________________

**Therapair Products Pty Ltd**  
Signature: _________________________  
Name: [AUTHORIZED REPRESENTATIVE]  
Title: [TITLE]  
Date: _________________________

---

**Document Version:** 1.0  
**Last Updated:** October 28, 2025  
**Legal Review Required:** Yes  
**Next Review:** November 28, 2025
